Etoricoxib, a COX-2 inhibitor has been linked to a possible increase in risk of coronary and cerebrovascular thrombotic events, heart failure, hypertension, and oedema. GI perforation, ulceration, or bleeding are other risks to be considered with etoricoxib therapy.
Trial results have shown that the 60-mg dose is effective...
account